TMS Therapy and Spravato as a combination therapy to heal depression
TMS therapy, or transcranial magnetic stimulation therapy, is a non-invasive treatment that uses magnetic fields to stimulate specific areas of the brain. It is commonly used to treat treatment-resistant depression, anxiety, and other mental health conditions. Recently, the FDA approved the use of a new medication, Spravato, to be used in combination with TMS therapy.
Spravato, also known as esketamine,is a nasal spray that restores the balance of certain neurotransmitters in the brain. It is used to treat adults with treatment-resistant depression. When used together with TMS therapy, the combined approach yields the rapid onset of relief commonly experienced with ketamine infusions, with the longer-term benefits observed with TMS treatments.
Another advantage of using TMS therapy and Spravato together is that it can lead to faster symptom improvement. In clinical trials, patients who received the combination therapy showed significant improvement in their symptoms within the first week of treatment, while those who received only one of the treatments showed improvement after several weeks. This rapid improvement can be crucial for those with severe depression who need relief as soon as possible.
Overall, the combination of TMS therapy and Spravato offers a promising new option for treating depression. By using a personalized approach and potentially providing faster symptom improvement, this combination therapy may be a valuable addition to the arsenal of treatments available for those with depression.
Do you know someone suffering from treatment resistant depression? Please share with those who might need it,whether it’s a friend, coworker, or loved one you know is struggling.